Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Withdrawn 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Breast 1

Conditions

Vomiting 1Rectal Neoplasms 1Patient Compliance 1Nausea 1Liver Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Acupuncture Points × Clear all
NCT00430313 2023-03-29

Effects of Acupoint Electro-stimulation on Preventing Nausea and Vomiting Induced by Cisplatin or Oxaliplatin

M.D. Anderson Cancer Center

Phase NA Withdrawn
Gastrointestinal

Liver Neoplasms, Nausea, Vomiting

NCT05041751 2022-05-17

Myofascial Release or Trigger Point Injections for the Reduction of Post-Mastectomy Pain Syndrome

M.D. Anderson Cancer Center

Phase NA Withdrawn
Breast

Breast Neoplasms

NCT04749381 2021-02-11

RCT

Peking University Cancer Hospital & Institute

Phase 2 Unknown
264 enrolled
Gastrointestinal

Patient Compliance, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡